Author:
Fu Xian-Hua,Li Jun,Huang Jian-Jin,Zheng Shu,Zhang Su-Zhan
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference25 articles.
1. Zhang Y, Banerjee S, Wang Z, Xu H, Zhang L, Mohammad R, Aboukameel A, Adsay NV, Che M, Abbruzzese JL, Majumdar AP, Sarkar FH (2006) Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. Cancer Res 66:1025–1032
2. Matsuda K, Idezawa T, You XJ, Kothari NH, Fan H, Korc M (2002) Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor. Cancer Res 62:5611–5617
3. Quatrale AE, Porcelli L, Silvestris N, Colucci G, Angelo A, Azzariti A (2011) EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence. Front Biosci 16:1962–1972
4. Gutierrez C, Schiff R (2011) HER2: biology, detection, and clinical implications. Arch Pathol Lab Med 135:55–62
5. Beltran GB, Yabar BA (2010) HER2 expression in gastric cancer in Peru. Rev Gastroenterol Peru 30:324–327